Pain & InflammationPrescriptionTablets

Dysera-K

Diclofenac Potassium and Serratiopeptidase Tablets.

Dosage Form
Tablets
Pack Sizes
10 × 10 Tablets
Status
Prescription
Business Enquiry →View Product ↓
Dysera-K Diclofenac Potassium and Serratiopeptidase tablets 10 × 10 carton
Product Overview

About Dysera-K

Dysera-K is a tablets formulation containing Diclofenac Potassium IP, Serratiopeptidase IP. Pronounced analgesic effect in 15–30 minutes in non-rheumatic moderate to severe pain.

FormTablets
Available In10 × 10 Tablets
ClassificationPrescription

  1. Step 01

    What is in the formula

    A 2-active formulation combining Diclofenac Potassium IP and Serratiopeptidase IP, transcribed from the composition panel exactly as printed.

    • Diclofenac Potassium IP — strength not published
    • Serratiopeptidase IP — strength not published

  2. Step 02

    How the dose is presented

    Presented as tablets in 10 × 10 Tablets. The pack panel carries the full handling direction.

    • Dosage form — Tablets
    • Pack size — 10 × 10 Tablets

  3. Step 03

    Where the prescriber directs it

    The pack prints 7 indications. They are reproduced on this page without addition; the prescribing decision stays with the physician.

    • Rehabilitation programmes
    • Periarthritis
    • Low back pain syndrome
    • Neurolathyrism

  4. Step 04

    Dispensed under prescription

    As directed by the Physician.

Composition

Composition & Key Information

Composition of Dysera-K
IngredientStrength / Details
Diclofenac Potassium IP—
Serratiopeptidase IP—

Strengths pending confirmation. Some values on the supplied pack panel could not be transcribed with certainty, so they are omitted rather than shown unverified. Refer to the product pack for complete strength details.

Product Specifications

Brand NameDysera-K
Dosage FormTablets
Pack Sizes10 × 10 Tablets
Regulatory StatusPrescription
CategoryPain & Inflammation
DivisionPharmaceutical
DosageAs directed by the Physician.
Key actives

What each active is

No filler copy and no borrowed claims. Each card names an active exactly as the Dysera-K composition panel prints it, with its pharmacopoeial class and the strength on the carton.

  • Non-steroidal anti-inflammatory

    Diclofenac Potassium IP

    Strength not published

    Diclofenac Potassium and Serratiopeptidase Tablets.

  • Proteolytic enzyme

    Serratiopeptidase IP

    Strength not published

    Diclofenac Potassium and Serratiopeptidase Tablets.

Strengths marked as not published could not be transcribed from the supplied pack scan with confidence. They are withheld rather than estimated — the printed carton remains the authority.

Product Highlights

Key Product Information

01

Diclofenac Potassium and Serratiopeptidase Tablets.

02

Pronounced analgesic effect in 15–30 minutes in non-rheumatic moderate to severe pain.

Indications

Therapeutic Indications

  • Rehabilitation programmes
  • Periarthritis
  • Low back pain syndrome
  • Neurolathyrism
  • Painful reflex muscle spasm
  • Trapezitis
  • Post-cerebral stroke spasticity

Course timeline

From the printed panel

The Dysera-K carton prints no onset, no duration of effect and no outcome, so none is published here. What it does document is a course — four phases, each carrying the panel text that governs it.

01Dispensing

Before the pack is opened

On the pack

  • The pack carries no prescription restriction; qualified advice still applies.

In practice

  • Confirm the classification printed on the carton — Tablets, 10 × 10 Tablets.

What follows

The pack leaves the counter intact, with its seal and batch details readable.

02First dose

Opening the pack

On the pack

  • The pack is used as supplied; no reconstitution step is printed.

In practice

  • Check the carton and its seal are intact and undamaged.
  • Read the batch number, manufacturing date and expiry printed on the pack.

What follows

From here the schedule belongs to the prescriber, not to the carton.

03The course

For as long as prescribed

On the pack

  • As directed by the Physician.
  • The carton prints no schedule beyond this direction — 10 × 10 Tablets per pack, tablets.

In practice

  • Dose and interval are set by the prescriber — this page publishes no dosing schedule of its own.

What follows

What is left in the pack stays under the storage conditions printed on it.

04Storage & shelf

Between doses, and in the warehouse

On the pack

  • Store as printed on the carton.

In practice

  • Rotate stock first-expiry-first-out.

What follows

Expiry is the date printed on the carton — nothing on this page extends it.

Packaging

Packaging & Availability

Dysera-K packaging

Available Pack Sizes

10 × 10 Tablets

Product Form

Tablets

Marketed By

Vistra Biotech Pharma

Patna, Bihar, India

Business Enquiry

Interested in Dysera-K?

Contact Vistra Biotech Pharma for distribution, PCD franchise, product dossiers, and business partnership opportunities for Dysera-K and the complete Dysera product range.

Submit Business Enquiry →Call +91 91623 55919

Vistra Biotech Pharma — pharmaceutical marketing and distribution since June 2019.